CoChat

Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1

Open access
Lawson, Alexander J., Walker, Elizabeth A., Lavery, Gareth G., Bujalska, Iwona J., Hughes, Beverly, Arlt, Wiebke, Stewart, Paul M., Ride, Jonathan P. · 2011 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

In peripheral target tissues, levels of active glucocorticoid hormones are controlled by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), a dimeric enzyme that catalyzes the reduction of cortisone to cortisol within the endoplasmic reticulum. Loss of this activity results in a disorder termed cortisone reductase deficiency (CRD), typified by increased cortisol clearance and androgen excess. To date, only mutations in H6PD , which encodes an enzyme supplying cofactor for the reaction, have been identified as the cause of disease. Here we examined the HSD11B1 gene in two cases presenting with biochemical features indicative of a milder form of CRD in whom the H6PD gene was normal. Novel heterozygous mutations (R137C or K187N) were found in the coding sequence of HSD11B1 . The R137C mutation disrupts salt bridges at the subunit interface of the 11β-HSD1 dimer, whereas K187N affects a key active site residue. On expression of the mutants in bacterial and mammalian cells, activity was either abolished (K187N) or greatly reduced (R137C). Expression of either mutant in a bacterial system greatly reduced the yield of soluble protein, suggesting that both mutations interfere with subunit folding or dimer assembly. Simultaneous expression of mutant and WT 11β-HSD1 in bacterial or mammalian cells, to simulate the heterozygous condition, indicated a marked suppressive effect of the mutants on both the yield and activity of 11β-HSD1 dimers. Thus, these heterozygous mutations in the HSD11B1 gene have a dominant negative effect on the formation of functional dimers and explain the genetic cause of CRD in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1014934108

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. NF Taylor, WA Bartlett, DJ Dawson, Cortisone reductase deficiency: Evidence for a new inborn error in metabolism of adrenal steroids. J Endocrinol 102S, 1 (1984).
  2. MW Savage, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency. J Endocrinol 129S, 1 (1991).

Cited by

See all 61

Metadata

Authors
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P.
Affiliations
  • School of Biosciences and
  • University of Birmingham (GB)
Venue
Proceedings of the National Academy of Sciences
Published
2011-02-15
Volume
108
Issue
10
Pages
4111-4116
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1982600255
Cited by
61
References
35
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 7 · 2013: 7 · 2012: 8
FWCI
6.29
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Wellcome Trust (066357, 074088)
  • National Institute for Health and Care Research (NF-SI-0508-10356)
  • Biotechnology and Biological Sciences Research Council (BB/G023468/1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
11β-hydroxysteroid dehydrogenase type 1, heterozygous mutation, dominant negative effect, salt bridges, subunit interface, active site residues, cortisol clearance, hyperandrogenism, glucocorticoid metabolism
MeSH terms
Amino Acid Sequence, Animals, Cell Line, Female, Heterozygote, Hirsutism, Humans, Hydrocortisone, Male, Molecular Sequence Data, Mutation, Pedigree, Sequence Homology, Amino Acid, Dimerization, Catalytic Domain, 11-beta-Hydroxysteroid Dehydrogenases, Steroid Metabolism, Inborn Errors, 11-beta-Hydroxysteroid Dehydrogenase Type 1, 46, XX Disorders of Sex Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1. https://app.cochat.ai/papers/10.1073/pnas.1014934108
The paper
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011). Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1014934108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.